WO1998004211A1 - Endoluminal stent - Google Patents
Endoluminal stent Download PDFInfo
- Publication number
- WO1998004211A1 WO1998004211A1 PCT/HU1997/000042 HU9700042W WO9804211A1 WO 1998004211 A1 WO1998004211 A1 WO 1998004211A1 HU 9700042 W HU9700042 W HU 9700042W WO 9804211 A1 WO9804211 A1 WO 9804211A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stent
- network
- gold
- wire
- metal
- Prior art date
Links
- 229910052737 gold Inorganic materials 0.000 claims abstract description 17
- 239000010931 gold Substances 0.000 claims abstract description 17
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 15
- 210000004204 blood vessel Anatomy 0.000 claims abstract description 12
- 229910000510 noble metal Inorganic materials 0.000 claims abstract description 10
- 239000010970 precious metal Substances 0.000 claims abstract description 10
- 230000025033 vasoconstriction Effects 0.000 claims abstract description 9
- 238000003466 welding Methods 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 7
- 239000002184 metal Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 3
- 230000002452 interceptive effect Effects 0.000 claims 1
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 229910001316 Ag alloy Inorganic materials 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229910001362 Ta alloys Inorganic materials 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005555 metalworking Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 208000017497 prostate disease Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00395—Coating or prosthesis-covering structure made of metals or of alloys
- A61F2310/00419—Other metals
- A61F2310/00568—Coating made of gold or Au-based alloys
Definitions
- the present invention relates to endoluminal stent with tubular network stucture to eliminate the narrowing of blood vessels or other luminal passage ways of the human body, which stent disposed in the expanded location of the said lumen can stabilise the expanded diameter of it.
- the known endoluminal grafts or stents are used mainly to treat narrowing of blood vessels. It can be a network structure of metal wire or can be made of metal tube with slots by laser. These products are different by the metal-component and the design of the network.
- One of the well-known products is the slotted tube stent design of Johnson & Johnson Co, which has less diameter in elongated state, thus it is easy to dispose in the desired location of the lumen, wherein the rhomboidal structure opens and the stent will be shorter, simultaneously its diameter bigger.
- Some stent types are crimped on a balloon catheter, and in the lumen the stent will be enlarged with help blowing of the balloon, which just after will be removed from the blood vessel.
- stent are made of the special tissuefil and metalworking metal ,,316L Stainless Steel" produced for this purpose and keeps its network shape and size against the pressure of the lumen's wall. Further it is known and used other stents made of resilient material being unstable and tense at elongated state, therefore they dispose it closed in the lumen with help of a protection casing. After removing the said casing the self-expandable stent opens and steps in stabile state.
- the shape of Medtronic stent's network is a plurality of loops on both directions on a virtual cylindrical surface.
- the wire helix of Cordis stent includes a main helix line and a second one on it, quasi ..modulated" the main line by the second one.
- Cobalt- steel gives the resilient property to the structure.
- stents made of plastic material, and it is known the use of tantalum-alloy too.
- the Schneider Co produces a stent wherein the network lays between an inner and an outer coaxial catheter, just removing them after the stent is disposed in the desired location.
- the AVE Advanced- ced Vascular Engineering. uses multiple units defined as endless zig-zag line wire cylinders with welded joints one to other.
- the first object of present invention is to develop an endoluminal stent for stabilising the enlarged state of blood vessel or other endoluminal passageway producing with a quality according to medical requires in lower cost than the known products even in small series production.
- a further purpose of the present invention is to eliminate the drawbacks of the known products said in prior art, especially the bad X-ray contrast.
- the inventiv step based the present invention is the idea that we may eliminate the dangerous wire-ends and the linkages between the segments applying endless wire filament merely with one welding point on the conjoin of two end of said filament. It was recognized that may prove the satisfactory radial force against the wall-pres- sure of blood vessel with help spot welding on a few cross of filament.
- the invention is endoluminal stent with tubular network structure to eliminate the narrowing of blood vessels or other luminal passageways of the human body, which stent disposed in the expanded location of the said lumen to stabilize the expanded diameter of it, and in the state disposed in desired location of the blood vessel or the other luminal passageway of the human body the radial force of it is greater than the recoil of the blood vessel, and may characterized by that the network structure of the stent is made by an endless self contained monofilament of metal-wire.
- the said stent especially may characterized by that the 50-100% of the nodel cross of the network the crossing wire filaments are fixed one to other, preferably with help of spot welding. Also especially the said stent is made of noble metal or it is coated with precious metal.
- the longitudinal size of the network in our stent preferably may characterized by the general formula [ n.k + j ] . L wherein theticianL" is the length of one lead in the helix for any wire filament in the network, the ,,n" is an integral number especially between 5 and 24, the value ,,k" is 0,125, the value réellej" may be 0,06-0,13, so these means that the length of stent is about any multiple of the one eighth of theticianL".
- An other object is of this invention a stent to eliminate the narrowing of blood vessel or other endoluminal passageway of human body which may characterized in that the stent is made of noble metal, especially of gold, or is coated with precious metal, f.e. with gold.
- the invention will be demonstrated detail with help of the drawings but without limiting the claims to the examples of demonstration. Figures
- Figure 1 A view of an preferred embodiment of the stent according to the present invention.
- Figure 2. The theoretical schema of the structure of the stent according Fig.1.
- the stent 10 includes the wire 2 starting from the lower and upper loops 4 being accordingly the Fig.1. on the left end of the stent 10 and running along a virtual cylinder surface. Both left loop 4 is the start-point of an right-, and an left helix-line which more times cross 3 one the other on the said cylinder surface and finally its unite in the two loops 4 found before an behind on the right end of stent 10.
- the 50% of the nodel cross 3 of the network 1 the crossing wire filaments 2 are fixed one to the other with help of spot welding.
- the wire 2 composes thus the network 1 on the virtual cylinder surface forming an endless self-contained curveline.
- the said example is a network 1 having two loops 4 on its each end.
- the network openings may be at most 2,3 mm, what means a network 1 with at least four loops 4 on both ends further the network 1 is formed by four left-helix and four right- helix wires 2, but all the said wires 2 together create one monofilament. It is used embodiment with five, six or eight loops 4 both end of the network 1.
- the wire 2 is made of the commercial 316L stainless steel or of with treated reinforced gold or of gold coated wire-metal.
- the proposed diameter of the stent 10 for coronary blood vessel is 3-5 mm made of about 0,2 mm diameter wire 2, for peripheral blood vessels 3-12 mm diameter of stent with about 0,3 mm diameter wire 2.
- the stent diameter must be 10-15 mm and the wire diameter 0,3-0,4 mm, further it is proposed for swalling throat (i.e. gullet) 28 mm stent diameter with about 0,5 mm wire diameter.
- the stent must supplied at least eight-eight wire 2, except the coronary disease for what is enough four-four left and right helix line to create the network 1.
- Using precious metal may apply also the silver or the gold-silver alloy instead of with crystalline treat reinforced gold.
- the lead angle of network 1 may be 45°-60° concerning to the end plane of the structure's virtual cylinder.
- the length of the stent 10 is the summerized length of the united networks 1. The length of the network 1 is a function of the lead but against it we may define it in a wide range.
- the length of the network 1 must be an integral multiple of the suboctuple lead [,,L"] because the three-dimen- sionai monofilament network may best form on this way.
- the ,,L" length we can reasonable accept as period-length because inside of this length all wire-segments, starting whether to left or right direction from the loops 4, make a whole spiral-lead.
- our network 1 is 8 mm long in enlarged state and 10 mm long in elongated state.
- the 20 mm long enlarging balloon we achieve the stent- length accordingly the 20 mm long enlarging balloon and this stent 10 is very flexible consequently its two part construction against it length.
- the network 1 has a length characterized with the formula : 0,125 n L + j.L wherein the provoken" is a simple integral preferably in the scale 4 -12, the valve of ,,j" is in the range 0.06-0,13. Clearly about a suboctuple length-extension is necessary for the back-turning the filament i.e.
- the stent according to present invention is cheaper than the laser slotted network structure and may be produced economically also in smaller series. Compared to the known stents with network structure of wire the products of present invention has no free wire ending and despite it comprises only one welding for that. A number of reinforcing welding may be used additionally.
- the stent of present invention shows controllable X-ray visibility in the group of known stent, because of the amount and ratio of the noble metal used.
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97932958A EP0920286A1 (en) | 1996-07-31 | 1997-07-28 | Endoluminal stent |
AU36316/97A AU3631697A (en) | 1996-07-31 | 1997-07-28 | Endoluminal stent |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HUP9602099 | 1996-07-31 | ||
HU9602099A HU217501B (en) | 1996-07-31 | 1996-07-31 | Enlarging facing for blood-vessels |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998004211A1 true WO1998004211A1 (en) | 1998-02-05 |
Family
ID=89994172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/HU1997/000042 WO1998004211A1 (en) | 1996-07-31 | 1997-07-28 | Endoluminal stent |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0920286A1 (en) |
AU (1) | AU3631697A (en) |
HU (1) | HU217501B (en) |
WO (1) | WO1998004211A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9050205B2 (en) | 2004-05-25 | 2015-06-09 | Covidien Lp | Methods and apparatus for luminal stenting |
US9095343B2 (en) | 2005-05-25 | 2015-08-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9125659B2 (en) | 2004-05-25 | 2015-09-08 | Covidien Lp | Flexible vascular occluding device |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9320590B2 (en) | 2006-02-22 | 2016-04-26 | Covidien Lp | Stents having radiopaque mesh |
US9393021B2 (en) | 2004-05-25 | 2016-07-19 | Covidien Lp | Flexible vascular occluding device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US10004618B2 (en) | 2004-05-25 | 2018-06-26 | Covidien Lp | Methods and apparatus for luminal stenting |
USD898136S1 (en) | 2018-08-27 | 2020-10-06 | Coulter Ventures, Llc. | Implement for exercise rack |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1205743A (en) * | 1966-07-15 | 1970-09-16 | Nat Res Dev | Surgical dilator |
US4969458A (en) * | 1987-07-06 | 1990-11-13 | Medtronic, Inc. | Intracoronary stent and method of simultaneous angioplasty and stent implant |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
WO1992009246A1 (en) * | 1990-11-28 | 1992-06-11 | Numed, Inc. | Intravascular radially expandable stent and method |
US5195984A (en) | 1988-10-04 | 1993-03-23 | Expandable Grafts Partnership | Expandable intraluminal graft |
US5354308A (en) * | 1992-05-01 | 1994-10-11 | Beth Israel Hospital Association | Metal wire stent |
WO1995028895A1 (en) * | 1994-04-26 | 1995-11-02 | WILLY RüSCH AG | Self-expanding stent for hollow organs |
-
1996
- 1996-07-31 HU HU9602099A patent/HU217501B/en not_active IP Right Cessation
-
1997
- 1997-07-28 EP EP97932958A patent/EP0920286A1/en not_active Withdrawn
- 1997-07-28 AU AU36316/97A patent/AU3631697A/en not_active Abandoned
- 1997-07-28 WO PCT/HU1997/000042 patent/WO1998004211A1/en not_active Application Discontinuation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1205743A (en) * | 1966-07-15 | 1970-09-16 | Nat Res Dev | Surgical dilator |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4969458A (en) * | 1987-07-06 | 1990-11-13 | Medtronic, Inc. | Intracoronary stent and method of simultaneous angioplasty and stent implant |
US5195984A (en) | 1988-10-04 | 1993-03-23 | Expandable Grafts Partnership | Expandable intraluminal graft |
WO1992009246A1 (en) * | 1990-11-28 | 1992-06-11 | Numed, Inc. | Intravascular radially expandable stent and method |
US5354308A (en) * | 1992-05-01 | 1994-10-11 | Beth Israel Hospital Association | Metal wire stent |
WO1995028895A1 (en) * | 1994-04-26 | 1995-11-02 | WILLY RüSCH AG | Self-expanding stent for hollow organs |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9801744B2 (en) | 2004-05-25 | 2017-10-31 | Covidien Lp | Methods and apparatus for luminal stenting |
US11771433B2 (en) | 2004-05-25 | 2023-10-03 | Covidien Lp | Flexible vascular occluding device |
US9125659B2 (en) | 2004-05-25 | 2015-09-08 | Covidien Lp | Flexible vascular occluding device |
US10918389B2 (en) | 2004-05-25 | 2021-02-16 | Covidien Lp | Flexible vascular occluding device |
US9295568B2 (en) | 2004-05-25 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9050205B2 (en) | 2004-05-25 | 2015-06-09 | Covidien Lp | Methods and apparatus for luminal stenting |
US10004618B2 (en) | 2004-05-25 | 2018-06-26 | Covidien Lp | Methods and apparatus for luminal stenting |
US9393021B2 (en) | 2004-05-25 | 2016-07-19 | Covidien Lp | Flexible vascular occluding device |
US9855047B2 (en) | 2004-05-25 | 2018-01-02 | Covidien Lp | Flexible vascular occluding device |
US9095343B2 (en) | 2005-05-25 | 2015-08-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10433988B2 (en) | 2006-02-22 | 2019-10-08 | Covidien Lp | Stents having radiopaque mesh |
US9610181B2 (en) | 2006-02-22 | 2017-04-04 | Covidien Lp | Stents having radiopaque mesh |
US11382777B2 (en) | 2006-02-22 | 2022-07-12 | Covidien Lp | Stents having radiopaque mesh |
US9320590B2 (en) | 2006-02-22 | 2016-04-26 | Covidien Lp | Stents having radiopaque mesh |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9907643B2 (en) | 2012-10-30 | 2018-03-06 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9301831B2 (en) | 2012-10-30 | 2016-04-05 | Covidien Lp | Methods for attaining a predetermined porosity of a vascular device |
US10206798B2 (en) | 2012-10-31 | 2019-02-19 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US10952878B2 (en) | 2012-10-31 | 2021-03-23 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9561122B2 (en) | 2013-02-05 | 2017-02-07 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
USD898136S1 (en) | 2018-08-27 | 2020-10-06 | Coulter Ventures, Llc. | Implement for exercise rack |
Also Published As
Publication number | Publication date |
---|---|
HU217501B (en) | 2000-02-28 |
HUP9602099A1 (en) | 1998-08-28 |
HU9602099D0 (en) | 1996-09-30 |
EP0920286A1 (en) | 1999-06-09 |
AU3631697A (en) | 1998-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20010000043A1 (en) | Flexible expandable stent | |
US20010018595A1 (en) | Flexible expandable stent | |
US5725547A (en) | Corrugated stent | |
CA2195783C (en) | A flexible expandable stent | |
US7763068B2 (en) | Stent | |
EP2425800B1 (en) | Implantable intraluminal device and method of using same in treating aneurysms | |
EP0947180A3 (en) | Stent aneursym treatment system and method | |
US5860999A (en) | Stent and method of using same | |
US5503636A (en) | Self-expanding stent for hollow organs | |
EP1570807A2 (en) | Intralumenal stent device for use in body lumens of various diameters | |
KR20010035531A (en) | Longitudinally flexible stent | |
EP1087729A1 (en) | Self expanding bifurcated endovascular prosthesis | |
EP0920286A1 (en) | Endoluminal stent | |
KR100241822B1 (en) | Stent for expanding lumen | |
AU779582B2 (en) | A stent | |
AU2004203556B2 (en) | A Stent | |
AU3124699A (en) | A stent | |
KR20000002967A (en) | Stent for extending an inner cavity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997932958 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998508295 Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 1997932958 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997932958 Country of ref document: EP |